Presented By Geertjan Van Tienhoven at 2018 ASCO ......Geertjan van Tienhoven, AMC baseline...

Post on 01-Jun-2020

2 views 0 download

Transcript of Presented By Geertjan Van Tienhoven at 2018 ASCO ......Geertjan van Tienhoven, AMC baseline...

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC) : <br />A randomized, controlled, multicenter phase III trial of the<br /> Dutch Pancreatic Cancer Group

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Rationale

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Trial design

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Trial design

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Accrual

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

baseline characteristics

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Results

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Overall survival (ITT)

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Disease free survival

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Metastases and local recurrence (ITT)

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Subset analysis

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Conclusion

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting

Acknowledgements

Presented By Geertjan Van Tienhoven at 2018 ASCO Annual Meeting